BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 31204935)

  • 21. [Expression and Clinical Significance of Exosome Component 4 in Newly Diagnosed Patients with Diffuse Large B-Cell Lymphoma].
    Hong JQ; Huang QH; Huang ZY; Fan LP; Lin QY; Huang HB
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Dec; 31(6):1684-1689. PubMed ID: 38071046
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Analysis for clinicopathological features, therapy and prognosis of 30 elderly patients with non-Hodgkin's lymphoma].
    Wang HT; Yang B; Cai LL; Ran HH; Zhang WY; Zhu HL; Yang Y; Li SX; Fan H; Chi XH; Yu RL; Zhang F; Li BL; Lin J; Zhai B; Yao SQ; Lu XC
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Dec; 21(6):1464-70. PubMed ID: 24370030
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Clinical Features, Treatment and Prognostic Factors of 94 Patients with Follicular Lymphoma].
    DU XY; Hu K; Zhao W; Yang P; Wan W; Jing HM; Ke XY
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2018 Jun; 26(3):756-764. PubMed ID: 29950216
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Comparison of Different Staging Systems and Prognostic Analysis in 68 Cases of Primary Intestinal Diffuse Large B Cell Lymphoma].
    Wang X; Wang CY; Xu W; Yang HL; Zhao HF; Wang XF; Wang YF; Yu Y; Zhang YZ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2019 Feb; 27(1):52-60. PubMed ID: 30738447
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Primary site and regional lymph node involvement are independent prognostic factors for early-stage extranodal nasal-type natural killer/T cell lymphoma.
    Niu SQ; Yang Y; Li YY; Wen G; Wang L; Li ZM; Wang HY; Zhang LL; Xia YF; Zhang YJ
    Chin J Cancer; 2016 Apr; 35():34. PubMed ID: 27044275
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Expression of CD30 in Diffuse Large B Cell Lymphoma and Its Clinical Significance].
    Zhao YF; Qian SX
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Jun; 24(3):717-21. PubMed ID: 27342497
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Influence of the Ratio of Peripheral Hemoglobin-to-Red Cell Distribution width on the Prognosis of Patients with Diffuse Large B-cell Lymphoma].
    Dong XY; Tang GF; Chen W; Cao J; Cheng H; Li ZY; Xu KL
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Jun; 30(3):765-770. PubMed ID: 35680803
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of concordant and discordant bone marrow involvement on outcome in diffuse large B-cell lymphoma treated with R-CHOP.
    Sehn LH; Scott DW; Chhanabhai M; Berry B; Ruskova A; Berkahn L; Connors JM; Gascoyne RD
    J Clin Oncol; 2011 Apr; 29(11):1452-7. PubMed ID: 21383296
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Expression and clinical significance of Ki-67 in diffuse large B cell lymphoma].
    Zhou Y; Zhao Y; Bo J; Li YF; Ma C; Shi YN
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Oct; 21(5):1162-6. PubMed ID: 24156426
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Clinical Significance of Detecting CD4
    Liu W; Zhagn GX; Shi WZ; Dong L; Liu H; Shen XL
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Apr; 25(2):449-454. PubMed ID: 28446291
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Analysis of the Clinicopathological Characteristics, Treatment and Prognosis of Unclassifiable B-Cell Lymphoma Intermediated between DLCBL and BL].
    Liu DL; Wang B; Zhu YD; Yan F
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2018 Apr; 26(2):443-448. PubMed ID: 29665913
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Analysis of prognostic risk factors in patients with diffuse large B-cell lymphoma].
    Yu ZP; Ding JH; Chen BA; Gao C; Wang LL; Chen Z
    Zhonghua Xue Ye Xue Za Zhi; 2011 Dec; 32(12):830-5. PubMed ID: 22339956
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Limited usefulness of CA125 measurement in the management of Hodgkin's and non-Hodgkin's lymphoma.
    Bonnet C; Beguin Y; Fassotte MF; Seidel L; Luyckx F; Fillet G
    Eur J Haematol; 2007 May; 78(5):399-404. PubMed ID: 17419741
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Dose-intensive immunochemotherapy with or without autologous hematopoietic stem cell transplantation in the treatment of 29 newly diagnosed young patients with medium/high risk diffuse large B-cell lymphoma].
    Yi S; Liu W; Lyu R; Li Z; Xu Y; Sui W; Huang W; Wang T; Deng S; Liu H; Fu M; Zou D; Qiu L
    Zhonghua Xue Ye Xue Za Zhi; 2014 Jun; 35(6):546-50. PubMed ID: 24985182
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Mutational Spectrum and Prognosis Analysis of Young Patients with Diffuse Large B-Cell Lymphoma Based on Next-Generation Sequencing].
    Lyu LY; Nie YL; Renaguli A; Qi XL; Muhebaier A; Zhai SS; An L; Mao M; Li Y
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Apr; 31(2):403-410. PubMed ID: 37096512
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Correlation Analysis of Peripheral Blood B Cell Count with Clinical Features and Prognosis in Patients Newly Diagnosed with Diffuse Large B-Cell Lymphoma].
    Lu T; Mi H; Zhao DD; Yang SG; Bu YW; Zhang F; Chen WM; Sun DP
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2024 Apr; 32(2):458-465. PubMed ID: 38660852
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Expression of Bcl-2 gene and its effect on prognosis of patients with primary gastrointestinal diffuse large B-cell lymphoma].
    Zhang L; Zhao H; Li X; Xia B; Zheng H; Li H; Sun B; Zhang Y
    Zhonghua Zhong Liu Za Zhi; 2014 Oct; 36(10):755-60. PubMed ID: 25567306
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Clinicopathological characteristics and prognostic analysis of primary intestinal diffuse large B-cell lymphoma].
    Huang Y; Zhou S; He X; Gui L; Yang J; Liu P; Qin Y; Zhang C; Xing P; Yang S; Wang L; Zhou L; Dong M; Sun Y; Shi Y
    Zhonghua Yi Xue Za Zhi; 2015 Dec; 95(48):3895-8. PubMed ID: 27122208
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Analysis of survival and treatment outcome of young patients with high-risk diffuse large B cell lymphoma].
    Yang P; Jing HM; Zhao W; Hu K; Dong F; Li QH; Wan W; Tian L; Wang JJ; Ke XY
    Zhonghua Yi Xue Za Zhi; 2017 Aug; 97(32):2485-2490. PubMed ID: 28835053
    [No Abstract]   [Full Text] [Related]  

  • 40. Central Nervous System Involvement in Patients with Diffuse Large B Cell Lymphoma: Analysis of the Risk Factors and Prognosis from a Single-Center Retrospective Cohort Study.
    Ma J; Li Q; Shao J; Ma Y; Lin Z; Kang H; Chen B
    Cancer Manag Res; 2019; 11():10175-10185. PubMed ID: 31819650
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.